5 terminated. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
| Phase 3 | 1 | Terminated 1 |
Follow Emergencies: new trials by email Literature Review of Emergencies trials Research Report on Emergencies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) TNX-1300 (Injection), Placebo (Injection) - Cocaine Use, Cocaine Intoxication | Phase 2 | Terminated | Tonix Pharmaceuticals, Inc. | 3 | 2024-08-16 | 2025-06-24 |
| Paracervical Injection for Headache in the Emergency Department Paracervical injection, prochlorperazine and diphenhydramine.(Standard Treatment) - Headache Disorders, Primary, Pain Management | Phase 2 | Terminated | Christian Fromm, MD | 19 | 2020-09-15 | 2024-08-01 |
| Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED Nitric Oxide Gas, Inhaled Supplemental Oxygen - COVID19 | Phase 2 | Terminated | Massachusetts General Hospital | 47 | 2020-04-18 | 2022-01-06 |
| Triage Administration of Ondansetron for Gastroenteritis in Children Ondansetron, Placebos - Gastroenteritis | Phase 2 / Phase 3 | Terminated | St. Justine's Hospital | 81 | 2017-07-15 | 2020-10-22 |
| Impact of Emergency Department Probiotic Treatment of Diarrheal Illness on Daycare Attendance Lacidophil (experimental high dose), Lacidophil (experimental standard dose), Placebo - Gastroenteritis | Phase 2 | Terminated | The Hospital for Sick Children | 132 | 2009-04-01 | 2018-04-17 |
Gastroenteritis (2) · Agnosia (1) · COVID-19 (1) · Cocaine-Related Disorders (1) · Headache Disorders, Primary (1) · Respiratory Tract Infections (1)
Disease Attributes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Headache Disorders (1) · Infections (1) · Lung Diseases (1) · Mental Disorders (1) · Nervous System Diseases (1)
Endothelium-Dependent Relaxing Factors (1) · Injections (1) · Ondansetron (1) · Prochlorperazine (1) · cocaine esterase (1)
Christian Fromm, MD (1) · Massachusetts General Hospital (1) · St. Justine's Hospital (1) · The Hospital for Sick Children (1) · Tonix Pharmaceuticals, Inc. (1)
United States (3) · Canada (2)
Christian Fromm, MD (1) · Gregory Sullivan, MD (1) · Jocelyn Gravel, MD (1) · Stephen Freedman, MD (1)
U01DA056245 (1)